NAPLEX 2025-2026 Examination Questions with their
Verified A+ Answers Latest Update!
Terms in this set (49)
Which of the following It will decrease blood pressure.
statements concerning use of
Precedex in critical care patients is
correct?
A
It can only be used if the patient
is intubated.
B
It can only be used if the patient is
also receiving a paralytic.
C
It will decrease blood pressure.
D
It is indicated for use up to 72
hours.
E
It is more likely to cause delirium
than a benzodiazepine.
,MH is a 65 year old post- It can cause dangerous blood clots.
menopausal female with a
family history of breast cancer.
She was recently diagnosed with
osteoporosis and wants to know
if she can use raloxifene. Which
statement concerning
raloxifene is correct?
A
It increases the risk of breast
cancer.
B
It is not indicated for treatment of
osteoporosis.
C
It can cause dangerous blood clots.
D
The brand name is Prezista.
E
It reduces hot flashes and other
vasomotor symptoms.
The pharmacist performs a C
screening to see if JC requires Morbidity and Mortality Weekly Report
any immunizations. Which drug
references would be useful to D
The CDC's Pink Book
determine vaccine
requirements for JC? (Select ALL
that apply.)
Answ
er A
USP 800
B
The American Diabetes
Association Standards of
Medical Care
,C
Morbidity and Mortality Weekly
Report
D
The CDC's Pink Book
E
The FDA's Orange Book
, Which medication increases the C
risk for C. difficile infections Pantoprazole
and fractures if used long-
term?
Answ
er A
Metoclopram
ide B
Naprox
en C
Pantoprazole
D
Fluoxet
ine E
Simvastatin
The patient qualifies for a 60 mg, 7 days
fentanly patch because he
has been taking______ of
morphine equivalent daily for at
least_____________________ _.
tapentadol ER brand? Nucynta ER
A patient is receiving ribavirin as Teratogenic effects and hemolytic anemia
part of her hepatitis C regimen.
Which of the following are
boxed warnings for ribavirin?
Answ
er A
Teratogenic effects and lactic
acidosis
B
Lactic acidosis and hemolytic
anemia
C
Hemolytic anemia and vesicant
potential
D
Teratogenic effects and hemolytic
Verified A+ Answers Latest Update!
Terms in this set (49)
Which of the following It will decrease blood pressure.
statements concerning use of
Precedex in critical care patients is
correct?
A
It can only be used if the patient
is intubated.
B
It can only be used if the patient is
also receiving a paralytic.
C
It will decrease blood pressure.
D
It is indicated for use up to 72
hours.
E
It is more likely to cause delirium
than a benzodiazepine.
,MH is a 65 year old post- It can cause dangerous blood clots.
menopausal female with a
family history of breast cancer.
She was recently diagnosed with
osteoporosis and wants to know
if she can use raloxifene. Which
statement concerning
raloxifene is correct?
A
It increases the risk of breast
cancer.
B
It is not indicated for treatment of
osteoporosis.
C
It can cause dangerous blood clots.
D
The brand name is Prezista.
E
It reduces hot flashes and other
vasomotor symptoms.
The pharmacist performs a C
screening to see if JC requires Morbidity and Mortality Weekly Report
any immunizations. Which drug
references would be useful to D
The CDC's Pink Book
determine vaccine
requirements for JC? (Select ALL
that apply.)
Answ
er A
USP 800
B
The American Diabetes
Association Standards of
Medical Care
,C
Morbidity and Mortality Weekly
Report
D
The CDC's Pink Book
E
The FDA's Orange Book
, Which medication increases the C
risk for C. difficile infections Pantoprazole
and fractures if used long-
term?
Answ
er A
Metoclopram
ide B
Naprox
en C
Pantoprazole
D
Fluoxet
ine E
Simvastatin
The patient qualifies for a 60 mg, 7 days
fentanly patch because he
has been taking______ of
morphine equivalent daily for at
least_____________________ _.
tapentadol ER brand? Nucynta ER
A patient is receiving ribavirin as Teratogenic effects and hemolytic anemia
part of her hepatitis C regimen.
Which of the following are
boxed warnings for ribavirin?
Answ
er A
Teratogenic effects and lactic
acidosis
B
Lactic acidosis and hemolytic
anemia
C
Hemolytic anemia and vesicant
potential
D
Teratogenic effects and hemolytic
